In diabetics, cryptoxaneic acid (CCA) activates the Xc-/GPX4/NRF2 pathway and inhibits nuclear receptor coactivator 4 (NCOA4), thereby inhibiting ferroptosis (Zhou, 2020). Here, NCOA4 is linked to diabetes mellitus.